Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CBM588 + Ipilimumab + Nivolumab |
Synonyms | |
Therapy Description |
CBM588 is a probiotic that induces the release of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), which inhibits tumor cell growth (PMID: 23354042). |